Global immunohematology market size to expand at 5.6% CAGR through 2027
This research literature on ‘global immunohematology market’ is meticulously crafted to aid both existing and new aspirants to figure out and study the industry requirements, market size, and competition. The report is integrated with imperative insights on the future trends of this industry vertical in relation to the key growth catalysts, restraints, as well as the opportunities and associated risks.
Selbyville, Delaware, Feb. 18, 2021 (GLOBE NEWSWIRE) — According to industry experts, global
immunohematology market reached a valuation of USD 2 billion in 2019 and to reach USD 3.1 billion to register an appreciable CAGR of 5.6% over the forecast period 2020-2027. Increased pervasiveness of HIV and other target diseases is a major growth propeller for the industry. In fact, Joint United Nations Programme on HIV/AIDS (UNAIDS) stated that approximately 1.7 million new cases of HIV were registered in 2019.